Digital Checkup (575)

Providers need prescriptive analytics to lower their risk in value-based contracts, says Sheila Talton, CEO of Gray Matter Analytics.

COVID-19 has heightened public interest in vaccine and therapeutic research. It's time to build on that engagement, finding new ways to enroll volunteers in other clinical trials and improve the patient experience, says CCT President CJ Anderson.

Bob Chaput, founder of Clearwater Compliance, a cyber risk management firm, and author of the new book, "Stop the Cyber Bleeding," offers practical advice on how to turn an enterprise cyber risk management program into a business enabler.

Opioids, controlled substances, expensive oncology therapeutics and vaccines risk being stolen and sold on the black market. Tom Knight, CEO of Invistics, explains how supply chain visibility and inventory control tools help safeguard them.

Machine learning can help flag troubling patterns and improve systems moving forward, says Linguamatics' Dr. Elizabeth Marshall.

Hackers are using phishing attacks to take advantage of employees working from home to gain user names and passwords, says Christophe Doré, security manager at Capsule Technologies.

DrFirst President Cameron Deemer explains how practical machine learning applications can help improve safety and efficiency – automating medication history in hospital EHRs and aggregating patient records in consumer apps.

Personalized drug dosing can increase the efficacy and safety of medications, says InsightRX CEO Sirj Goswami.

Remote monitoring technology can expand the reach of clinical trials, says Jennifer Price, executive director of data and analytics at THREAD.

Amwell CEO Roy Schoenberg talks going public, M&As and what he is excited about in 2021.

From electronic case reporting to PDMP to disaster response, Executive Director Jay Nakashima says he's optimistic as network architecture improves and public-private data sharing efforts make progress.

Paul Brient, SVP and chief product officer at athenahealth, predicts telehealth visits will even out, IPOs will continue and venture eyes will remain on digital health in 2021.